Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 725.65
(1.82%)
INR 725.65
(1.82%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 12.38 Billion | 14.43 Billion | 12.3 Billion | 15.75 Billion | 12.67 Billion | 13.22 Billion |
| Cost of Revenue | 14.03 Billion | 7.88 Billion | 6.97 Billion | 7.69 Billion | 6.4 Billion | 7.46 Billion |
| Gross Profit | -1.65 Billion | 6.54 Billion | 5.32 Billion | 8.06 Billion | 6.26 Billion | 5.75 Billion |
| Operating Expenses | 2.55 Billion | 6.32 Billion | 5.5 Billion | 5.25 Billion | 4.57 Billion | 4.24 Billion |
| Selling, General and Administrative Expenses | 585.1 Million | 2.3 Billion | 364.2 Million | 404.7 Million | 338.5 Million | 239.49 Million |
| Research and Development Expenses | 559.8 Million | 461.6 Million | 656.2 Million | 643.5 Million | 585.7 Million | 440.5 Million |
| Other Expenses | 3.41 Billion | 225.5 Million | 76.3 Million | 84.6 Million | 107.9 Million | 74.67 Million |
| Cost and Expenses | 16.59 Billion | 14.21 Billion | 12.47 Billion | 12.95 Billion | 10.97 Billion | 11.71 Billion |
| Operating Income | -3.85 Billion | 275.9 Million | -259.89 Million | 2.84 Billion | 1.73 Billion | 1.5 Billion |
| Interest Expense | 1.03 Billion | 900.6 Million | 672.8 Million | 802.4 Million | 676.5 Million | 730.93 Million |
| Income Tax Expense | 785.4 Million | -225.7 Million | -328.1 Million | 1.5 Million | 3.9 Million | 5.9 Million |
| Earnings before Tax | -4.88 Billion | -448.1 Million | -911 Million | 2.21 Billion | 1.14 Billion | 676.93 Million |
| Net Income | -5.67 Billion | -221.7 Million | -581.5 Million | 2.21 Billion | 1.14 Billion | 595.27 Million |
| Earnings Per Share Basic | -145.27 | -6.16 | -16.18 | 69.00 | 44.29 | 24.11 |
| Earnings Per Share Diluted | -145.27 | -6.16 | -16.18 | 64.53 | 42.82 | 24.07 |
| Weighted Average Shares Outstanding | 39.05 Million | 35.99 Million | 35.94 Million | 32.08 Million | 25.87 Million | 24.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.05 Million | 35.99 Million | 35.94 Million | 34.31 Million | 26.76 Million | 24.72 Million |
| Gross Margin | -0.13 | 0.45 | 0.43 | 0.51 | 0.49 | 0.44 |
| EBIT Margin | -0.23 | 0.11 | 0.09 | 0.26 | 0.21 | 0.17 |
| Profit Margin | -0.46 | -0.02 | -0.05 | 0.14 | 0.09 | 0.05 |
| EBITDA | -2.82 Billion | 1.52 Billion | 885 Million | 4.13 Billion | 2.85 Billion | 2.32 Billion |
| Earnings Before Tax Margin | -0.31 | 0.02 | -0.02 | 0.18 | 0.14 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.46 Billion | 3.63 Billion | 12.88 Billion | 2.62 Billion | 2.48 Billion | 4.25 Billion |
| Cost of Revenue | 1.71 Billion | 2.81 Billion | 8.05 Billion | 1.59 Billion | 3.04 Billion | 2.37 Billion |
| Gross Profit | 1.75 Billion | 818.3 Million | 4.83 Billion | 1.02 Billion | -553.9 Million | 1.87 Billion |
| Operating Expenses | 1.39 Billion | 649.8 Million | 6.82 Billion | 1.18 Billion | 1.32 Billion | 1.76 Billion |
| Selling, General and Administrative Expenses | 610.4 Million | 649.8 Million | - | 736.8 Million | 1.21 Billion | 749.6 Million |
| Research and Development Expenses | - | - | - | 1.01 Billion | 108 Million | 110 Million |
| Other Expenses | 1.39 Billion | 5.6 Million | 53.7 Million | 17 Million | -1.31 Billion | 11.8 Million |
| Cost and Expenses | 3.1 Billion | 3.46 Billion | 14.87 Billion | 2.78 Billion | 4.36 Billion | 4.13 Billion |
| Operating Income | 359.7 Million | 168.5 Million | -1.93 Billion | -137.9 Million | -1.87 Billion | 126 Million |
| Interest Expense | 282.8 Million | 308.7 Million | 1.05 Billion | 306.9 Million | 253.7 Million | 244.4 Million |
| Income Tax Expense | 3.2 Million | - | 785.4 Million | 887.9 Million | 259.63 Million | 1 Million |
| Earnings before Tax | 80.1 Million | -134.6 Million | -4.88 Billion | -1.66 Billion | -2.75 Billion | -170.6 Million |
| Net Income | 80.1 Million | -134.6 Million | -5.67 Billion | -2.55 Billion | -2.75 Billion | -171.6 Million |
| Earnings Per Share Basic | 2.54 | -3.50 | - | -65.37 | -76.49 | -4.77 |
| Earnings Per Share Diluted | 2.54 | -3.50 | - | -65.37 | -76.49 | -4.77 |
| Weighted Average Shares Outstanding | 48.05 Million | 38.45 Million | 39.05 Million | 39.05 Million | 35.99 Million | 35.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.05 Million | 38.45 Million | 39.05 Million | 39.05 Million | 35.99 Million | 35.99 Million |
| Gross Margin | 0.50 | 0.23 | 0.38 | 0.39 | -0.22 | 0.44 |
| EBIT Margin | 0.18 | 0.12 | - | 0.04 | -0.65 | 0.09 |
| Profit Margin | 0.02 | -0.04 | -0.44 | -0.97 | -1.11 | -0.04 |
| EBITDA | 616.3 Million | 419.2 Million | - | 114.6 Million | -1.61 Billion | 388.1 Million |
| Earnings Before Tax Margin | 0.10 | 0.05 | -0.15 | -0.05 | -0.75 | 0.03 |
CPYYY
PAGS
PRKS
7707
0941
3495